BR9908631A - Glifosato como gameticida - Google Patents

Glifosato como gameticida

Info

Publication number
BR9908631A
BR9908631A BR9908631-0A BR9908631A BR9908631A BR 9908631 A BR9908631 A BR 9908631A BR 9908631 A BR9908631 A BR 9908631A BR 9908631 A BR9908631 A BR 9908631A
Authority
BR
Brazil
Prior art keywords
glyphosate
gameticide
plants containing
dna molecule
tolerance
Prior art date
Application number
BR9908631-0A
Other languages
English (en)
Inventor
Sherri M Brown
Michael E Fromm
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of BR9908631A publication Critical patent/BR9908631A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A01N57/20—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds containing acyclic or cycloaliphatic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8231—Male-specific, e.g. anther, tapetum, pollen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C12N15/8275—Glyphosate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289—Male sterility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção: <B>"GLIFOSATO COMO GAMETICIDA"<D>. Glifosato é usado como um gameticida altamente seletivo em plantas contendo em seu genoma uma primeira molécula de DNA que confere tolerância ao glifosato constitutiva e uma segunda molécula de DNA que inibe a dita tolerância ao glifosato especificamente em tecido reprodutor masculino. As plantas contendo as primeira e segundas moléculas de DNA são tornadas masculinas estéreis através de exposição ao glifosato. Os métodos e composições da invenção são vantajosos para uso na geração de semente híbrida, para restringir o cruzamento, a parra prolongar a vida da flor.
BR9908631-0A 1998-03-09 1999-03-09 Glifosato como gameticida BR9908631A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7727798P 1998-03-09 1998-03-09
PCT/US1999/005126 WO1999046396A2 (en) 1998-03-09 1999-03-09 Glyphosate as a gametocide

Publications (1)

Publication Number Publication Date
BR9908631A true BR9908631A (pt) 2000-11-14

Family

ID=22137136

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908631-0A BR9908631A (pt) 1998-03-09 1999-03-09 Glifosato como gameticida

Country Status (6)

Country Link
EP (1) EP1062354A2 (pt)
CN (1) CN1300324A (pt)
AR (1) AR016185A1 (pt)
AU (1) AU2992999A (pt)
BR (1) BR9908631A (pt)
WO (1) WO1999046396A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838593B2 (en) 2000-07-13 2005-01-04 Pioneer Hi-Bred Int'l Inc. Austin responsive promoter sequences and methods of using the same
EP1174512A1 (en) * 2000-07-17 2002-01-23 Peter Stamp Seed composition and method for reducing or preventing the release of genetically manipulated pollen
US6646186B1 (en) 2000-07-26 2003-11-11 Stine Seed Farm Inc. Hybrid soybeans and methods of production
CZ300073B6 (cs) 2000-09-29 2009-01-21 Monsanto Technology Llc Zpusob vylepšení tolerance vuci glyfosátu u rostliny pšenice, její bunka, její DNA, dvojice molekulDNA primeru, zpusoby její detekce, zpusob šírení vlastnosti tolerance vuci glyfosátu u rostlin, DNAdetekcní kit
AR031645A1 (es) * 2000-12-07 2003-09-24 D & Pl Technology Holding Corp Esterilidad macho en las plantas dicotiledoneas, inducida por el glyphosate
US7230168B2 (en) 2001-12-20 2007-06-12 The Curators Of The University Of Missouri Reversible male sterility in transgenic plants by expression of cytokinin oxidase
DE10163163A1 (de) 2001-12-20 2003-07-03 Basf Ag Verfahren zur Herstellung hochfunktioneller, Hyperverzweigter Polyester durch enzymatische Veresterung
EP2278017B1 (en) 2002-02-26 2015-03-25 Syngenta Limited A method of selectively producing male or female sterile plants
EP2298921B1 (en) 2003-02-12 2016-12-21 Monsanto Technology LLC Cotton event mon 88913 and compositions and methods for detection thereof
WO2004082366A2 (en) * 2003-03-19 2004-09-30 Regents Of The University Of Minnesota Methods to confer enhanced floral properties to plants
US20060200878A1 (en) 2004-12-21 2006-09-07 Linda Lutfiyya Recombinant DNA constructs and methods for controlling gene expression
WO2007047016A2 (en) 2005-10-13 2007-04-26 Monsanto Technology, Llc Methods for producing hybrid seed
ZA200803234B (en) * 2005-10-13 2009-01-28 Monsanto Technology Llc Methods for producing hybrid seed
BRPI0719815A2 (pt) * 2006-10-03 2014-05-20 Monsanto Technology Llc Métodos para produção de semente de milho híbrido e composições produzidas a partir dos mesmos
EP2074227A4 (en) 2006-10-12 2010-03-10 Monsanto Technology Llc PLANT MICRO-RNAS AND METHOD OF USE THEREOF
MX358629B (es) 2009-11-23 2018-08-28 Monsanto Technology Llc Evento transgenico de maiz mon 87427 y la escala de desarrollo relativo.
PE20141518A1 (es) 2011-07-01 2014-11-17 Monsanto Technology Llc Metodos y composiciones para la regulacion selectiva de la expresion de proteinas
CN103222423B (zh) * 2013-05-14 2014-11-12 安徽省农业科学院水稻研究所 一种水稻杂交育种材料及其培育方法与应用
BR112018001192B1 (pt) 2015-07-22 2024-02-06 Monsanto Technology Llc Molécula de dna recombinante, método para regular seletivamente a expressão de uma proteína em um tecido reprodutivo masculino de uma planta transgênica, e uso de uma planta ou semente que compreende a referida molécula de dna recombinante
CN112080501B (zh) * 2020-09-10 2021-11-23 隆平生物技术(海南)有限公司 重组启动子、基因表达盒及其在植物育种中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227835A (en) * 1988-02-03 1992-09-25 Paladin Hybrids Inc Antisense gene systems of pollination control for hybrid seed production
JP3173785B2 (ja) * 1990-08-31 2001-06-04 モンサント カンパニー グリホセート耐性５―エノールピルビルシキミ酸―３―ホスフェートシンターゼ

Also Published As

Publication number Publication date
AU2992999A (en) 1999-09-27
WO1999046396A3 (en) 1999-10-21
WO1999046396A2 (en) 1999-09-16
EP1062354A2 (en) 2000-12-27
AR016185A1 (es) 2001-06-20
CN1300324A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
BR9908631A (pt) Glifosato como gameticida
BR0206855A (pt) Composições e suas aplicações para o tratamento de defeitos em cartilagem articular
BR9707438A (pt) Esterilizador quìmico de ação rápida.
BRPI0500968A (pt) Emulsificador
BRPI0206708B8 (pt) composição sólida, composição para hemostasia, vedação de tecido e colagem de tecido, e, usos de um veículo de colágeno
BR0017268A (pt) Composição farmacêutica de propofol, aquosa, lìmpida, estável na esterilização em autoclave, apropriada para administração parenteral, e processo para a preparação de uma composição farmacêutica de propofol, aquosa, lìmpida, estável na esterilização em autoclave, apropriada para administração parenteral
BR9812562A (pt) Composição aquosa espessada, processo para limpeza de crostas de cal, e, uso de uma mistura ácida
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR9812018A (pt) Composições farmacêuticas de meloxicam com solubilidade e biodisponibilidade melhoradas
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
BR9912240A (pt) Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos
BR0109983A (pt) Estratrienos substituìdos por 8.beta-hidrocarbila como estrogênios seletivamente eficientes
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9909626A (pt) Compostos que inibem a ligação de integrina a seus receptores
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
BR9908722A (pt) Uso de derivados de ácido fumárico na medicina de transplante
BR9713785A (pt) Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto e para o tratamento da dor, de distúrbios gastrointestinais e de lesões na coluna vertebral.
BRPI9914741A (pt) n-(2-aril-proprionil)-sulfonamidas, usos e composições farmacêuticas contendo as mesmas.
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
DE69822668D1 (de) Heterozyklische ether- und thioether-verbindungen, verwendbar zur steuerung von chemischer synaptischer transmission
BRPI0718615B8 (pt) processo para produzir um material elástico a partir de tropoelastina e material elástico
BR0311723A (pt) Materias ortopédicos derivados de queratina
BRPI0416650A (pt) composição de lipossoma estável para a aplicação de um agente farmacêutico, composição de lipossoma estéril e estável para a aplicação de um agente farmacêutico método para a produção de uma composição de lipossoma estável para a aplicação de um agente farmacêutico, composição farmacêutica, uso de uma composição de lipossoma, dispositivo para conter uma composição de lipossoma estável, kit para a aplicação de um agente farmacêutico a um paciente, método para aumentar a estabilidade de composições de lipossomas, método para a identificação de uma composição de lipossoma estável na fase, composição de lipossoma e composição de lipossoma estável na fase
BR0011055A (pt) Método de esterilização

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTA A 5O, 6O, 7O E 8O ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.